In 1180 high-risk adults undergoing major surgery, a biomarker-guided KDIGO preventive care strategy vs usual care reduced moderate or severe AKI within 72 h (14.4% vs 22.3%; OR 0.57, 95% CI 0.40-0.79; 1176 analysed), with no difference in adverse events.
RCTn = 1,180
Zarbock et al. A preventive care strategy to reduce moderate or severe acute kidney injury after major surgery (BigpAK-2); a multinational, randomised clinical trial